| Schedule of Reconciliation of Net Income and Number of Shares in the Calculation of Basic and Diluted Net Income per Share |
A reconciliation of net income and the number of shares in the calculation of basic and diluted net income per share is as follows (in thousands, except share and per share amounts): | | | | | | | | | | | | | Three Months Ended
March 31 | | 2025 | | 2024 | | Basic net income per common share: | | | | | Numerator: | | | | | Net income | $ | 15,059 | | $ | 16,898 | | | | | | Denominator: | | | | | Weighted-average shares used in computing basic net income per share | 85,499,153 | | 96,484,657 | | Basic net income per share | $ | 0.18 | | $ | 0.18 | | | | | | Diluted net income per common share: | | | | | Numerator: | | | | | Net income | $ | 15,059 | | $ | 16,898 | | | | | | Denominator: | | | | | Weighted-average shares used in computing basic net income per share | 85,499,153 | | 96,484,657 | | Effect of dilutive securities | | | | | Options to purchase common stock | 3,176,495 | | 3,922,757 | | Shares issuable under ESPP | — | | 809 | | Warrants to purchase common stock | — | | 291,643 | | Restricted stock units | 632,286 | | 353,067 | | Total effect of dilutive securities | 3,808,781 | | 4,568,276 | | Weighted-average shares used in computing diluted net income per share | 89,307,934 | | 101,052,933 | | Diluted net income per share | $ | 0.17 | | $ | 0.17 |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following weighted-average outstanding shares of potentially dilutive securities were excluded from the computation of diluted income per share for the period presented because including them would have been antidilutive: | | | | | | | | | | | | | Three Months Ended
March 31, | | 2025 | | 2024 | | Options to purchase common stock | 14,856,451 | | 12,631,505 | | Shares issuable under ESPP | 2,768 | | — | | Restricted stock units | 2,221,536 | | 814,281 | | Total | 17,080,755 | | 13,445,786 |
|